review article | Q7318358 |
scholarly article | Q13442814 |
P2093 | author name string | Timothy A McKinsey | |
P2860 | cites work | Identification of a transcriptional repressor related to the noncatalytic domain of histone deacetylases 4 and 5 | Q22011186 |
Translating the Histone Code | Q22065840 | ||
mHDA1/HDAC5 histone deacetylase interacts with and represses MEF2A transcriptional activity | Q22253463 | ||
Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation | Q24290523 | ||
Activation of the myocyte enhancer factor-2 transcription factor by calcium/calmodulin-dependent protein kinase-stimulated binding of 14-3-3 to histone deacetylase 5 | Q24290618 | ||
Protein kinase D regulates the fission of cell surface destined transport carriers from the trans-Golgi network | Q24290905 | ||
Enzymatic activity associated with class II HDACs is dependent on a multiprotein complex containing HDAC3 and SMRT/N-CoR | Q24292197 | ||
CaM kinase II selectively signals to histone deacetylase 4 during cardiomyocyte hypertrophy | Q24293269 | ||
MARKK, a Ste20-like kinase, activates the polarity-inducing kinase MARK/PAR-1 | Q24296268 | ||
Tyrosine phosphorylation of protein kinase D in the pleckstrin homology domain leads to activation | Q24297827 | ||
HDAC6 is a microtubule-associated deacetylase | Q24298013 | ||
Class II histone deacetylases: versatile regulators | Q24300376 | ||
Comprehensive proteomic analysis of human Par protein complexes reveals an interconnected protein network | Q24301939 | ||
Protein kinase C nu/protein kinase D3 nuclear localization, catalytic activation, and intracellular redistribution in response to G protein-coupled receptor agonists | Q44391310 | ||
Dose-dependent blockade to cardiomyocyte hypertrophy by histone deacetylase inhibitors | Q44449807 | ||
Atypical PKC phosphorylates PAR-1 kinases to regulate localization and activity | Q44844574 | ||
Silent information regulator 2alpha, a longevity factor and class III histone deacetylase, is an essential endogenous apoptosis inhibitor in cardiac myocytes | Q45108317 | ||
Protein kinase D specifically mediates apoptosis signal-regulating kinase 1-JNK signaling induced by H2O2 but not tumor necrosis factor | Q45310564 | ||
Protein kinase D1 and the beta 1 integrin cytoplasmic domain control beta 1 integrin function via regulation of Rap1 activation. | Q46659681 | ||
Inhibition of histone deacetylation blocks cardiac hypertrophy induced by angiotensin II infusion and aortic banding | Q46870302 | ||
Histone H2A.z is essential for cardiac myocyte hypertrophy but opposed by silent information regulator 2alpha. | Q50730852 | ||
Myocardin induces cardiomyocyte hypertrophy. | Q52022542 | ||
Targeted expression of calmodulin increases ventricular cardiomyocyte proliferation and deoxyribonucleic acid synthesis during mouse development. | Q52096362 | ||
Expression and activity of protein kinase D/protein kinase C mu in myocardium: evidence for alpha1-adrenergic receptor- and protein kinase C-mediated regulation. | Q52166952 | ||
EMK protein kinase-null mice: dwarfism and hypofertility associated with alterations in the somatotrope and prolactin pathways. | Q52174453 | ||
Targeted developmental overexpression of calmodulin induces proliferative and hypertrophic growth of cardiomyocytes in transgenic mice. | Q52224205 | ||
Angiotensin II-mediated protein kinase D activation stimulates aldosterone and cortisol secretion in H295R human adrenocortical cells. | Q53599311 | ||
Histone acetyltransferase activity of p300 is required for the promotion of left ventricular remodeling after myocardial infarction in adult mice in vivo. | Q53637690 | ||
MAPs, MARKs and microtubule dynamics. | Q55068033 | ||
Protein kinase D directly phosphorylates histone deacetylase 5 via a random sequential kinetic mechanism | Q57358995 | ||
Myocyte Enhancer Factors 2A and 2C Induce Dilated Cardiomyopathy in Transgenic Mice | Q57396513 | ||
New role for hPar-1 kinases EMK and C-TAK1 in regulating localization and activity of class IIa histone deacetylases | Q24303533 | ||
An expression screen reveals modulators of class II histone deacetylase phosphorylation | Q24304114 | ||
Association of class II histone deacetylases with heterochromatin protein 1: potential role for histone methylation in control of muscle differentiation | Q24307379 | ||
LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1 | Q24310603 | ||
MARK, a novel family of protein kinases that phosphorylate microtubule-associated proteins and trigger microtubule disruption | Q24313701 | ||
Protein kinase MARK/PAR-1 is required for neurite outgrowth and establishment of neuronal polarity | Q24317775 | ||
The protein kinase complement of the human genome | Q24324497 | ||
The transcriptional coactivator CAMTA2 stimulates cardiac growth by opposing class II histone deacetylases | Q24328902 | ||
Protein kinase D mediates a stress-induced NF-kappaB activation and survival pathway | Q24337864 | ||
Role of the regulatory domain of protein kinase D2 in phorbol ester binding, catalytic activity, and nucleocytoplasmic shuttling | Q24530618 | ||
MEF-2 function is modified by a novel co-repressor, MITR | Q24534397 | ||
HDAC4 deacetylase associates with and represses the MEF2 transcription factor | Q24534407 | ||
The DnaJ-related factor Mrj interacts with nuclear factor of activated T cells c3 and mediates transcriptional repression through class II histone deacetylase recruitment | Q24537306 | ||
HDAC4, a human histone deacetylase related to yeast HDA1, is a transcriptional corepressor | Q24554388 | ||
Protein kinases C and D mediate agonist-dependent cardiac hypertrophy through nuclear export of histone deacetylase 5 | Q24561772 | ||
Signal-dependent activation of the MEF2 transcription factor by dissociation from histone deacetylases | Q24682791 | ||
Gbetagamma-mediated regulation of Golgi organization is through the direct activation of protein kinase D | Q28140180 | ||
Association of COOH-terminal-binding protein (CtBP) and MEF2-interacting transcription repressor (MITR) contributes to transcriptional repression of the MEF2 transcription factor | Q28140525 | ||
Inactivation of the myocyte enhancer factor-2 repressor histone deacetylase-5 by endogenous Ca(2+) //calmodulin-dependent kinase II promotes depolarization-mediated cerebellar granule neuron survival | Q28191655 | ||
Roles of cardiac transcription factors in cardiac hypertrophy | Q28207623 | ||
Human HDAC7 histone deacetylase activity is associated with HDAC3 in vivo | Q28207885 | ||
Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy | Q28219383 | ||
Regulation of the polarity kinases PAR-1/MARK by 14-3-3 interaction and phosphorylation | Q28263242 | ||
An overview of the KIN1/PAR-1/MARK kinase family | Q28265396 | ||
Protein kinase D regulates vesicular transport by phosphorylating and activating phosphatidylinositol-4 kinase IIIbeta at the Golgi complex | Q28267260 | ||
Protein kinase D is a novel mediator of cardiac troponin I phosphorylation and regulates myofilament function | Q28290449 | ||
Protein kinase D1 phosphorylates HDAC7 and induces its nuclear export after T-cell receptor activation | Q28300399 | ||
Histone deacetylase 4 controls chondrocyte hypertrophy during skeletogenesis | Q28505748 | ||
MEF2 is upregulated during cardiac hypertrophy and is required for normal post-natal growth of the myocardium | Q28506129 | ||
Protein kinase D protects against oxidative stress-induced intestinal epithelial cell injury via Rho/ROK/PKC-delta pathway activation | Q37036685 | ||
Interaction between protein kinase Cmu and the vanilloid receptor type 1. | Q38335651 | ||
PKCepsilon-PKD1 signaling complex at Z-discs plays a pivotal role in the cardiac hypertrophy induced by G-protein coupling receptor agonists | Q39400583 | ||
Essential role for protein kinase D family kinases in the regulation of class II histone deacetylases in B lymphocytes | Q40322638 | ||
GSK-3beta directly phosphorylates and activates MARK2/PAR-1. | Q40356675 | ||
Myocyte enhancer factor 2 acetylation by p300 enhances its DNA binding activity, transcriptional activity, and myogenic differentiation | Q40435172 | ||
Dual phospholipase C/diacylglycerol requirement for protein kinase D1 activation in lymphocytes. | Q40482280 | ||
AKAP-Lbc nucleates a protein kinase D activation scaffold | Q40512904 | ||
The CRM1 nuclear export receptor controls pathological cardiac gene expression | Q40586178 | ||
Activation loop Ser744 and Ser748 in protein kinase D are transphosphorylated in vivo. | Q40798561 | ||
Regulation of cardiac stress signaling by protein kinase d1. | Q41496270 | ||
Local InsP3-dependent perinuclear Ca2+ signaling in cardiac myocyte excitation-transcription coupling | Q41919774 | ||
Protein kinase D activation by mutations within its pleckstrin homology domain. | Q42448861 | ||
Protein kinase Cmu downregulation of tumor-necrosis-factor-induced apoptosis correlates with enhanced expression of nuclear-factor-kappaB-dependent protective genes | Q42463364 | ||
Protein kinase D activation by deletion of its cysteine-rich motifs | Q42475083 | ||
Activation of protein kinase D by signaling through Rho and the alpha subunit of the heterotrimeric G protein G13. | Q42508695 | ||
Regulated nucleocytoplasmic transport of protein kinase D in response to G protein-coupled receptor activation | Q42824508 | ||
Protein kinase D potentiates DNA synthesis and cell proliferation induced by bombesin, vasopressin, or phorbol esters in Swiss 3T3 cells | Q42826316 | ||
Protein kinase C phosphorylates protein kinase D activation loop Ser744 and Ser748 and releases autoinhibition by the pleckstrin homology domain. | Q44198663 | ||
Cooperation of Gq, Gi, and G12/13 in protein kinase D activation and phosphorylation induced by lysophosphatidic acid | Q44246034 | ||
Histone deacetylase 7 maintains vascular integrity by repressing matrix metalloproteinase 10 | Q28509194 | ||
Activated glycogen synthase-3 beta suppresses cardiac hypertrophy in vivo | Q28511213 | ||
The transcriptional corepressor MITR is a signal-responsive inhibitor of myogenesis | Q28513025 | ||
Aldosterone, through novel signaling proteins, is a fundamental molecular bridge between the genetic defect and the cardiac phenotype of hypertrophic cardiomyopathy | Q28570951 | ||
A small molecular activator of cardiac hypertrophy uncovered in a chemical screen for modifiers of the calcineurin signaling pathway | Q28572337 | ||
Calcium/calmodulin-dependent protein kinase activates serum response factor transcription activity by its dissociation from histone deacetylase, HDAC4. Implications in cardiac muscle gene regulation during hypertrophy | Q28572531 | ||
The transcriptional coactivator p300 plays a critical role in the hypertrophic and protective pathways induced by phenylephrine in cardiac cells but is specific to the hypertrophic effect of urocortin | Q28572612 | ||
Cardiac p300 Is Involved in Myocyte Growth with Decompensated Heart Failure | Q28576829 | ||
Histone deacetylases 5 and 9 govern responsiveness of the heart to a subset of stress signals and play redundant roles in heart development | Q28592216 | ||
C-TAK1 regulates Ras signaling by phosphorylating the MAPK scaffold, KSR1 | Q28609091 | ||
LKB1 is the upstream kinase in the AMP-activated protein kinase cascade | Q28610414 | ||
Chromatin modifications by methylation and ubiquitination: implications in the regulation of gene expression | Q29619380 | ||
Acetylation and deacetylation of non-histone proteins | Q29619636 | ||
Microtubule affinity-regulating kinase 2 functions downstream of the PAR-3/PAR-6/atypical PKC complex in regulating hippocampal neuronal polarity | Q30445622 | ||
A phosphorylation state-specific antibody recognizes Hsp27, a novel substrate of protein kinase D. | Q31149618 | ||
Identification and cloning of Kidins220, a novel neuronal substrate of protein kinase D. | Q33918643 | ||
Suppression of class I and II histone deacetylases blunts pressure-overload cardiac hypertrophy | Q33929939 | ||
Immune system dysfunction and autoimmune disease in mice lacking Emk (Par-1) protein kinase. | Q33968074 | ||
Mechanisms and models in heart failure: the biomechanical model and beyond | Q34422770 | ||
Structure of the autoinhibited kinase domain of CaMKII and SAXS analysis of the holoenzyme | Q34472571 | ||
Protein kinase C-dependent protein kinase D activation modulates ERK signal pathway and endothelial cell proliferation by vascular endothelial growth factor | Q34496547 | ||
Structure-function of the multifunctional Ca2+/calmodulin-dependent protein kinase II. | Q34586783 | ||
Regulation of type II PIP kinase by PKD phosphorylation | Q35070394 | ||
Collaborative spirit of histone deacetylases in regulating chromatin structure and gene expression | Q35097666 | ||
CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo | Q35159705 | ||
Protein kinase D: a family affair | Q35163946 | ||
Cardiomyocyte calcium and calcium/calmodulin-dependent protein kinase II: friends or foes? | Q35641837 | ||
Molecular cloning and characterization of protein kinase D: a target for diacylglycerol and phorbol esters with a distinctive catalytic domain | Q35731354 | ||
MARKing tau for tangles and toxicity. | Q35902808 | ||
Statin therapy for cardiac hypertrophy and heart failure | Q35936804 | ||
Protein kinase D signaling | Q36035199 | ||
The cardiac fibroblast: therapeutic target in myocardial remodeling and failure | Q36094597 | ||
Mammalian PAR-1 determines epithelial lumen polarity by organizing the microtubule cytoskeleton | Q36322073 | ||
Phosphorylation of histone deacetylase 7 by protein kinase D mediates T cell receptor-induced Nur77 expression and apoptosis | Q36402725 | ||
Sirtuins in aging and age-related disease. | Q36549075 | ||
P433 | issue | 4 | |
P304 | page(s) | 667-677 | |
P577 | publication date | 2006-12-05 | |
P1433 | published in | Cardiovascular Research | Q4642329 |
P1476 | title | Derepression of pathological cardiac genes by members of the CaM kinase superfamily | |
P478 | volume | 73 |